Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ibrutinib/rituximab

Hepatitis B virus infection reactivation leading to liver failure: case report

    • 4 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Malek A, et al. Hepatitis b virus reactivation in patients with hematologic malignancies after anticancer therapy which included ibrutinib. Open Forum Infectious Diseases 6 (Suppl. 2): S156-S157 (plus poster) abstr. 288, Oct 2019. Available from: URL: http://doi.org/10.1093/ofid/ofz360.363 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ibrutinib/rituximab. Reactions Weekly 1791, 134 (2020). https://doi.org/10.1007/s40278-020-74979-1

    Download citation